THERALINK TECHNOLOGIES, INC. (OBMP) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
8000 INNOVATION PARK BATON ROUGE, LA 70820 |
| State of Incorp. | NV |
| Fiscal Year End | September 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2023 MRQ | 9/30/2023 | 12/31/2022 MRQ | 9/30/2022 | 9/30/2021 | 9/30/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 998 | 1,133 | 397 | 325 | 1,790 | 21 | |||
| Cash and cash equivalents | 997 | 1,131 | 393 | 314 | 1,779 | 21 | |||
| Short-term investments | 1 | 2 | 4 | 11 | 11 | ||||
| Receivables | 24 | 48 | 32 | ||||||
| Deferred costs | 27 | ||||||||
| Other undisclosed current assets | 240 | 198 | 190 | 314 | 278 | 41 | |||
| Total current assets: | 1,263 | 1,379 | 647 | 639 | 2,068 | 62 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 19 | 53 | 65 | 111 | 158 | ||||
| Operating lease, right-of-use asset | 1,104 | 1,142 | 1,155 | 169 | 206 | 24 | |||
| Property, plant and equipment | 449 | 655 | 686 | 699 | 745 | 2 | |||
| Deferred costs | 27 | ||||||||
| Other undisclosed noncurrent assets | 15 | 19 | 19 | 21 | 19 | 6 | |||
| Total noncurrent assets: | 1,587 | 1,870 | 1,952 | 1,000 | 1,128 | 32 | |||
| TOTAL ASSETS: | 2,850 | 3,248 | 2,599 | 1,639 | 3,196 | 94 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 374 | 832 | 1,232 | 1,236 | 746 | 2,175 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 40 | 13 | ||||
| Employee-related liabilities | ✕ | ✕ | ✕ | 193 | 133 | 73 | |||
| Accounts payable | 675 | 731 | 1,019 | 617 | 620 | ||||
| Accrued liabilities | 374 | 157 | 268 | 71 | 57 | 1,554 | |||
| Deferred revenue | 145 | 177 | 157 | 135 | |||||
| Debt | 30 | 730 | 55 | 49 | 43 | 3,478 | |||
| Deferred compensation liability | 94 | 561 | 383 | 186 | 33 | ||||
| Derivative instruments and hedges, liabilities | 16,426 | 42,466 | 9,320 | ||||||
| Disposal group, including discontinued operation | 205 | 687 | |||||||
| Business combination, contingent consideration, liability | 86 | 80 | 78 | ||||||
| Due to related parties | ✕ | ✕ | 1,209 | 1,122 | 373 | ||||
| Other liabilities | 12,976 | 71 | |||||||
| Other undisclosed current liabilities | 9,704 | 321 | 1,551 | 498 | 164 | ||||
| Total current liabilities: | 39,835 | 46,377 | 3,456 | 3,296 | 1,191 | 16,032 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 4 | 23 | 1,638 | 288 | 313 | ||||
| Long-term debt, excluding current maturities | 446 | 65 | |||||||
| Finance lease, liability | 4 | 23 | 34 | 88 | 136 | ||||
| Liabilities, other than long-term debt | 1,126 | 1,150 | |||||||
| Operating lease, liability | 1,126 | 1,150 | 1,158 | 134 | 177 | ||||
| Other undisclosed noncurrent liabilities | 148 | (134) | (177) | ||||||
| Total noncurrent liabilities: | 1,131 | 1,174 | 2,944 | 288 | 313 | ||||
| Total liabilities: | 40,965 | 47,551 | 6,400 | 3,584 | 1,504 | 16,032 | |||
| Temporary equity, carrying amount | 2,000 | ||||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | (38,116) | (44,303) | (6,801) | (4,945) | (308) | (15,937) | |||
| Common stock | 615 | 615 | 615 | 512 | 512 | 0 | |||
| Additional paid in capital | 55,024 | 54,386 | 55,392 | 44,368 | 42,368 | 10,652 | |||
| Accumulated deficit | (93,755) | (99,304) | (62,808) | (49,826) | (43,188) | (26,590) | |||
| Other undisclosed equity, attributable to parent | 0 | ||||||||
| Other undisclosed equity | 3,000 | 3,000 | |||||||
| Total equity: | (38,116) | (44,303) | (3,801) | (1,945) | (308) | (15,937) | |||
| TOTAL LIABILITIES AND EQUITY: | 2,850 | 3,248 | 2,599 | 1,639 | 3,196 | 94 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2023 TTM | 9/30/2023 | 12/31/2022 TTM | 9/30/2022 | 9/30/2021 | 9/30/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 125 | 544 | 568 | 506 | 181 | |||
| Cost of revenue | (126) | (192) | (225) | (117) | (53) | |||
| Other undisclosed gross profit | 482 | |||||||
| Gross profit: | 481 | 352 | 343 | 388 | 129 | |||
| Operating expenses | (9,460) | (13,186) | (11,983) | (5,954) | (3,485) | (1,769) | ||
| Operating loss: | (8,979) | (12,834) | (11,640) | (5,566) | (3,357) | (1,769) | ||
| Nonoperating income (expense) | (21,928) | (34,852) | (1,102) | 94 | 187 | (7,634) | ||
| Gain (loss), foreign currency transaction, before tax | (23) | 49 | ||||||
| Interest and debt expense | (5,434) | (6,393) | (1,095) | 227 | 165 | (77) | ||
| Loss from continuing operations before income taxes: | (36,342) | (54,079) | (13,837) | (5,244) | (3,005) | (9,480) | ||
| Other undisclosed income from continuing operations | 77 | |||||||
| Loss from continuing operations: | (36,342) | (54,079) | (13,837) | (5,244) | (3,005) | (9,402) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (12,189) | (13,837) | (5,244) | (3,005) | (9,402) | |
| Net loss: | (36,342) | (54,079) | (13,837) | (5,244) | (3,005) | (9,402) | ||
| Other undisclosed net income (loss) attributable to parent | 5,434 | 6,393 | 1,095 | (227) | (165) | |||
| Net loss attributable to parent: | (30,908) | (47,686) | (12,742) | (5,472) | (3,170) | (9,402) | ||
| Preferred stock dividends and other adjustments | (2,006) | |||||||
| Other undisclosed net loss available to common stockholders, basic | (39) | (219) | (240) | (1,167) | ||||
| Net loss available to common stockholders, basic: | (30,947) | (47,905) | (12,982) | (6,638) | (5,176) | (9,402) | ||
| Interest on convertible debt | ||||||||
| Dilutive securities, effect on basic earnings per share | ||||||||
| Net income (loss) available to common stockholders, diluted: | (30,947) | (47,905) | (12,982) | (6,638) | (5,176) | (9,402) | ||
Comprehensive Income ($ in thousands)
| 12/31/2023 TTM | 9/30/2023 | 12/31/2022 TTM | 9/30/2022 | 9/30/2021 | 9/30/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (36,342) | (54,079) | (13,837) | (5,244) | (3,005) | (9,402) | ||
| Comprehensive loss, net of tax, attributable to parent: | (36,342) | (54,079) | (13,837) | (5,244) | (3,005) | (9,402) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.